Paragraph
However, the following deferral periods shall apply for the infections listed in the table:
| Brucellosis (*) | 2 years following the date of full recovery |
| Osteomyelitis | 2 years after confirmed cured |
| Q fever (*) | 2 years following the date of confirmed cure |
| Syphilis (*) | 1 year following the date of confirmed cure |
| Toxoplasmosis (*) | 6 months following the date of clinical recovery |
| Tuberculosis | 2 years following the date of confirmed cure |
| Rheumatic fever | 2 years following the date of cessation of symptoms, unless evidence of chronic heart disease |
Fever >38°C | 2 weeks following the date of cessation of symptoms |
| Flu-like illness | 2 weeks after cessation of symptoms |
Malaria (*) | |
| — individuals who have lived in a malarial area within the first five years of life | 3 years following return from last visit to any endemic area, provided person remains symptom free; may be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation. |
| — individuals with a history of malaria | 3 years following cessation of treatment and absence of symptoms. Donations may be accepted thereafter only if an immunologic or molecular genomic test is negative |
| — asymptomic visitors to endemic areas | 6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative |
| — individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area | 3 years following resolution of symptoms; may be reduced to 4 months if an immunologic or molecular test is negative |
| F1West Nile Virus (WNV) (*) | 28 days after leaving a risk area of locally acquired West Nile Virus unless an individual Nucleic Acid Test (NAT) is negative |
Annotations
Textual amendments
- F1
Words in Sch. Pt. 3 para. 2.2.1 Table substituted (18.7.2016) by The Blood Safety and Quality (Amendment) Regulations 2016 (S.I. 2016/604), regs. 1, 2(2)